prikaz prve stranice dokumenta Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab
Embargo period 2025-04-01
Professional paper - Letter to the editor
Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab
Annals of Hematology, 103 (2023), 3; 1015-1016. https://doi.org/10.1007/s00277-023-05565-z
Lucijanić, Marko; Sabljić, Anica; Vlasac Glasnović, Josipa; Sorić, Ena; Jonjić, Željko; Kušec, Rajko

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Lucijanić, M., Sabljić, A., Vlasac Glasnović, J., Sorić, E., Jonjić, Ž. & Kušec, R. (2023). Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab. Annals of Hematology, 103. (3), 1015-1016. doi: 10.1007/s00277-023-05565-z

Lucijanić, Marko, et al. "Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab." Annals of Hematology, vol. 103, no. 3, 2023, pp. 1015-1016. https://doi.org/10.1007/s00277-023-05565-z

Lucijanić, Marko, Anica Sabljić, Josipa Vlasac Glasnović, Ena Sorić, Željko Jonjić and Rajko Kušec. "Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab." Annals of Hematology 103, no. 3 (2023): 1015-1016. https://doi.org/10.1007/s00277-023-05565-z

Lucijanić, M., et al. (2023) 'Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab', Annals of Hematology, 103(3), pp. 1015-1016. doi: 10.1007/s00277-023-05565-z

Lucijanić M, Sabljić A, Vlasac Glasnović J, Sorić E, Jonjić Ž, Kušec R. Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab. Annals of Hematology [Internet]. 2023 November 25 [cited 2024 November 26];103(3):1015-1016. doi: 10.1007/s00277-023-05565-z

M. Lucijanić, A. Sabljić, J. Vlasac Glasnović, E. Sorić, Ž. Jonjić and R. Kušec, "Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab", Annals of Hematology, vol. 103, no. 3, pp. 1015-1016, November 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:633355. [Accessed: 26 November 2024]

Metadata
Title (english)Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab
AuthorMarko Lucijanić
AuthorAnica Sabljić
AuthorJosipa Vlasac Glasnović
AuthorEna Sorić
AuthorŽeljko Jonjić
AuthorRajko Kušec
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Keywords (english)
Languageenglish
Publication typeProfessional paper - Letter to the editor
Publication statusPublished
Peer reviewPeer review
Publication versionAccepted version
Journal titleAnnals of Hematology
Numberingvol. 103, no. 3, pp. 1015-1016
p-ISSN0939-5555
e-ISSN1432-0584
DOIhttps://doi.org/10.1007/s00277-023-05565-z
URN:NBNurn:nbn:hr:105:633355
Publication2023-11-25
Document URLhttps://link.springer.com/10.1007/s00277-023-05565-z
Type of resourceText
Access conditionsEmbargoed access
Embargo expiration date: 2025-04-01
Terms of useLicence In copyright icon
Created on2024-05-06 08:06:45